Clinical Trial Update: Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Erasmus Medical Center examining whether statins can prevent progression of atherosclerosis in patients receiving immune chec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Melanoma

Drugs mentioned

• Statins

Snippet

Sponsor: Erasmus Medical Center | Conditions: Atherosclerosis, Melanoma | Phase 4 | Status: NOT_YET_RECRUITING